Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01247298 · ClinicalTrials.gov registry record · Early Phase 1
A Pilot Study of Trans Arterial Chemoembolization (TACE), Followed by Stereotactic Radiation Therapy (SBRT) for Patients With Hepatocellular Carcinoma
A Early Phase 1 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 17
- Enrollment target
NCT01247298 is a Early Phase 1 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 17 participants.
The verdict
NCT01247298, a Early Phase 1 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 17 participants
- Enrollment target
Study Summary
This investigational study will evaluate if using a combination of TACE along with high dose SBRT would show improvement in local control in patients with Hepatocellular Carcinoma.
Interventions
- COMBINATION_PRODUCT Stereotactic Body Radiation Therapy (SBRT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2010-10 |
| Est. Completion | 2016-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01247298
The ClinicalTrials.gov registry entry for NCT01247298 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Stereotactic Body Radiation Therapy (SBRT) is the first listed.
NCT01247298 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01247298 about?
NCT01247298 is a clinical study titled "A Pilot Study of Trans Arterial Chemoembolization (TACE), Followed by Stereotactic Radiation Therapy (SBRT) for Patients With Hepatocellular Carcinoma". This investigational study will evaluate if using a combination of TACE along with high dose SBRT would show improvement in local control in patients with Hepatocellular Carcinoma.
What is the current status of trial NCT01247298?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 17 participants. The study started on 2010-10. Estimated completion is 2016-12.
What interventions are being tested in trial NCT01247298?
The interventions under investigation include: Stereotactic Body Radiation Therapy (SBRT) (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT01247298?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.